genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2011
Unigene Laboratories
News
Unigene Regains Oral rPTH Osteoporosis Candidate from GSK
News
Unigene and Nordic Set Up Joint Venture to Develop Three Peptide Therapeutics
News
Unigene Divests Site-Directed Bone Growth Patents to Kieran Murphy
Bioprocessing
Unigene and GSK Broaden Deal in Anticipation of Phase III Trial in Postmenopausal Osteoporosis
Bioprocessing
Unigene to Produce Clinical Material for Cara’s Phase I-Stage Peptide Drug
News
Unigene Drops a Third of Its Staff and Restructures to Achieve 2010 Savings of $9–10M
Insights
Improving Stability While Adding Value
Scroll Up
Scroll Up
